6-42989619-C-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_006245.4(PPP2R5D):c.36C>A(p.Pro12=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006245.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP2R5D | NM_006245.4 | c.36C>A | p.Pro12= | synonymous_variant | 2/16 | ENST00000485511.6 | NP_006236.1 | |
PPP2R5D | NM_180976.3 | c.36C>A | p.Pro12= | synonymous_variant | 2/16 | NP_851307.1 | ||
PPP2R5D | NM_001270476.2 | c.-435C>A | 5_prime_UTR_variant | 2/16 | NP_001257405.1 | |||
PPP2R5D | NM_180977.3 | c.27+4915C>A | intron_variant | NP_851308.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP2R5D | ENST00000485511.6 | c.36C>A | p.Pro12= | synonymous_variant | 2/16 | 1 | NM_006245.4 | ENSP00000417963 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461190Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726902
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | PPP2R5D: PM2:Supporting, BP4, BP7 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.